Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma ; volume:04 ; number:03 ; year:2020
Konferenz: PAIRS Annual Meeting; 2020-02-26; Grand Hyatt Hotel, Dubai UAE
The Arab journal of interventional radiology ; 04, Heft 03 (2020)
- Beteiligte Personen und Organisationen
-
Matsumoto, Monica M.
Saxena, Priyali
Gabr, Ahmed
Riaz, Ahsun
Lewandowski, Robert J.
Salem, Riad
Mouli, Samdeep K.
- DOI
-
10.1055/s-0041-1729040
- URN
-
urn:nbn:de:101:1-2021081211465075346362
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Matsumoto, Monica M.
- Saxena, Priyali
- Gabr, Ahmed
- Riaz, Ahsun
- Lewandowski, Robert J.
- Salem, Riad
- Mouli, Samdeep K.
Ähnliche Objekte (12)
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres